Can implantation still fail in a female of childbearing age with acne?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Implantation Still Fail in Women with Acne?

Yes, implantation can absolutely still fail in women with acne, and the primary concern is whether the patient is taking isotretinoin (Accutane), which is highly teratogenic and requires mandatory dual contraception—but even with perfect contraceptive use, no method is 100% effective, meaning pregnancy (and thus implantation) remains possible. 1

Critical Context: Isotretinoin and Pregnancy Risk

The most important consideration for women of childbearing age with acne is whether they are taking systemic isotretinoin, as this creates a unique high-risk scenario:

  • Isotretinoin is absolutely contraindicated in pregnancy due to severe teratogenic effects causing retinoic acid embryopathy and congenital malformations. 2
  • Despite the iPLEDGE risk management program mandating dual contraception, approximately 150 isotretinoin-exposed pregnancies still occur annually in the United States due to contraceptive noncompliance. 2
  • Nearly one-third of women of childbearing potential admitted noncompliance with iPLEDGE pregnancy prevention requirements; among sexually active women, 29% did not comply with the dual contraception requirement. 2

Contraceptive Failure Rates and Implantation Risk

Even with the most effective contraceptive methods, implantation can still occur:

Long-Acting Reversible Contraception (LARC)

  • Contraceptive implants (etonogestrel): 0.05% typical use failure rate, meaning 5 in 10,000 women will become pregnant in the first year. 2
  • Levonorgestrel IUD: 0.2% typical use failure rate. 2
  • Copper IUD: 0.8% typical use failure rate. 2

Combined Hormonal Methods

  • Combined oral contraceptives, patch, or ring: 9% typical use failure rate (1 in 11 women). 2
  • DMPA injection: 6% typical use failure rate. 2

Barrier Methods

  • Male condoms: 18% typical use failure rate. 2
  • Female condoms: 21% typical use failure rate. 2

Mechanism of Contraceptive Action vs. Implantation

A critical distinction: Most contraceptives work BEFORE implantation, not by preventing it:

  • IUDs (both copper and levonorgestrel) primarily prevent fertilization by inhibiting sperm motility and thickening cervical mucus; inhibiting implantation is NOT believed to be a primary mechanism of action. 2
  • Contraceptive implants work by suppressing ovulation and thickening cervical mucus, preventing fertilization before implantation would occur. 2
  • When these methods fail (which they can), fertilization and implantation can proceed normally, resulting in pregnancy. 2

Acne Treatment and Contraceptive Interactions

Certain acne treatments can reduce contraceptive effectiveness, increasing implantation risk:

  • Isotretinoin drug interactions: A drug interaction that decreases effectiveness of hormonal contraceptives has not been entirely ruled out for isotretinoin. 1
  • Hepatic enzyme-inducing drugs (certain antibiotics used for acne) can impair efficacy of combined hormonal methods and implants. 2
  • Patients should be cautioned not to self-medicate with St. John's Wort, as it may decrease hormonal contraceptive effectiveness, with pregnancies reported in users of combined hormonal contraceptives who also used St. John's Wort. 1

Clinical Algorithm for Women with Acne

If Patient is Taking Isotretinoin:

  1. Verify enrollment in iPLEDGE and confirm dual contraception use (one primary + one secondary method). 1
  2. Counsel that contraceptive failure is still possible even with perfect use—no method is 100% effective. 2
  3. If unprotected intercourse occurs: Patient must stop isotretinoin immediately, have pregnancy test at least 19 days after last unprotected contact, resume dual contraception for one month, then have second pregnancy test before resuming therapy. 1
  4. If pregnancy occurs: Discontinue isotretinoin immediately and refer to Obstetrician-Gynecologist experienced in reproductive toxicity; report to FDA MedWatch (1-800-FDA-1088) and iPLEDGE Pregnancy Registry (1-866-495-0654). 1

If Patient is Taking Other Acne Treatments:

  • Topical retinoids (tretinoin, adapalene, tazarotene): Pregnancy Category C; should be avoided in pregnancy despite lower risk than oral isotretinoin. 3, 4
  • Safer alternatives if pregnancy occurs: Azelaic acid 20% (Category B), topical erythromycin (Category B), topical clindamycin (Category B), or benzoyl peroxide (minimal systemic absorption). 3, 4

Common Pitfalls to Avoid

  • Do not assume dual contraception eliminates pregnancy risk—even the most effective methods have failure rates, and implantation can still occur. 2
  • Do not overlook contraceptive noncompliance—nearly one-third of women admit not following iPLEDGE requirements. 2
  • Do not forget to counsel about drug interactions—certain antibiotics and supplements can reduce hormonal contraceptive effectiveness. 2, 1
  • Do not delay pregnancy testing if unprotected intercourse occurs—isotretinoin must be stopped immediately and pregnancy ruled out. 1

Adverse Effects of Contraceptive Implants Related to Acne

Acne is a recognized adverse effect of contraceptive implants, which may complicate management in women already being treated for acne:

  • Acne is one of the most frequent adverse events reported with implantable contraceptives (both levonorgestrel and etonogestrel systems). 5
  • Other common adverse effects include headaches, weight gain, emotional lability, and irregular bleeding. 2, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Skincare Ingredients Contraindicated in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Topical Tretinoin and Birth Defects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can implantation fail even if I experience implantation cramps during In Vitro Fertilization (IVF)?
If a patient experiences mild intermittent pinching or tugging sensations and is taking letrozole (7.5mg), does implantation failure still remain a possibility?
Can implantation failure trigger an early menstrual period?
What are the initial approaches to managing female infertility with implantation issues?
What are the potential adverse drug reactions (ADRs) associated with the Mirena (levonorgestrel) implant in females of reproductive age?
How should a patient with iron deficiency anemia take iron supplements while also taking proton pump inhibitors (PPIs) for gastrointestinal issues?
What is the recommended pain reliever for a pediatric patient experiencing a toothache?
Can implantation failure occur in a female of childbearing age experiencing acne during the implantation period, approximately 6-10 days after fertilization?
In a woman with acne taking isotretinoin (13-cis retinoic acid), does experiencing acne before implantation is complete necessarily mean 100% implantation success of her contraceptive method, such as an intrauterine device (IUD) or contraceptive implant?
Can a patient with a history of acne, currently treated with isotretinoin (13-cis retinoic acid) and using a contraceptive method, such as an intrauterine device (IUD) or subdermal implant, experience acne at 10 days post-ovulation (10dpo) despite successful implantation of the contraceptive device?
Do all pregnancies exhibit nipple changes, considering my history of acne and isotretinoin (13-cis-retinoic acid) use, and having experienced nipple changes in only half of my previous pregnancies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.